References
- Mehl AL, Thomson V. The Colorado newborn hearing screening project, 1992–1999: on the threshold of effective population-based universal newborn hearing screening. Pediatrics. 2002; 109:E7.1177357510.1542/peds.109.1.e7
- Morton CC. Genetics, genomics and gene discovery in the auditory system. Hum Mol Genet. 2002; 11: 1229-40.10.1093/hmg/11.10.122912015283
- Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken). 2012; 295:1837-50.2304523110.1002/ar.22578
- Xie J, Talaska AE, Schacht J. New developments in aminoglycoside therapy and ototoxicity. Hear Res. 2011; 281:28-37.10.1016/j.heares.2011.05.00821640178
- del Castillo FJ, Rodriguez-Ballesteros M, Martin Y, Arellano B, Gallo-Teran J, Morales-Angulo C, et al. Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet. 2003; 40:632-6.1292008010.1136/jmg.40.8.632
- Li R, Xing G, Yan M, Cao X, Liu XZ, Bu X, et al. Cosegregation of C-insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss. Am J Med Genet A. 2004; 124A:113-7.10.1002/ajmg.a.20305
- Yuan H, Qian Y, Xu Y, Cao J, Bai L, Shen W, et al. Cosegregation of the G7444A mutation in the mitochondrial COI/tRNA(Ser(UCN)) genes with the 12S rRNA A1555G mutation in a Chinese family with aminoglycoside-induced and nonsyndromic hearing loss. Am J Med Genet A. 2005; 138A:133-40.10.1002/ajmg.a.30952
- Wang X, Lu J, Zhu Y, Yang A, Yang L, Li R, et al. Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families. Pharmacogenet Genomics. 2008; 18:1059-70.1882059410.1097/FPC.0b013e3283131661
- Rahman S, Ecob R, Costello H, Sweeney MG, Duncan AJ, Pearce K, et al. Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study. BMJ Open. 2012; 2:e000411.10.1136/bmjopen-2011-00041122223843
- Estivill X, Govea N, Barcelo E, Badenas C, Romero E, Moral L, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet. 1998; 62:27-35.10.1086/3016769490575
- Al-Malky G, Suri R, Sirimanna T, Dawson SJ. Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated? Int J Pediatr Otorhinolaryngol. 2014; 78:969-73.10.1016/j.ijporl.2014.02.015
- Kaul M, Barbieri CM, Pilch DS. Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity. J Am Chem Soc. 2006; 128: 1261-71.10.1021/ja056159z16433544
- Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol. 2011; 2011:937861.22121370